A short-term treatment with resveratrol improves the inflammatory conditions of Middle-aged mice skeletal muscles

References

• Ballak SB, Busé-Pot T, Harding PJ, Yap MH, Deldicque L, de Haan A, Jaspers RT, Degens H. 2016. Blunted angiogenesis and hypertrophy are associated with increased fatigue resistance and unchanged aerobic capacity in old overloaded mouse muscle. Age. 38(2):39.
   PubMedGoogle Scholar
• Bamman MM, Clarke MSF, Talmadge RJ, Feeback DL. 1999. Enhanced protein electrophoresis technique for separating human skeletal muscle myosin heavy chain isoforms. Electrophoresis. 20(3):466–468.
   PubMed Web of Science ®Google Scholar
• Bresciani L, Calani L, Bocchi L, Delucchi F, Savi M, Ray S, Brighenti F, Stilli D, Del Rio D. 2014. Bioaccumulation of resveratrol metabolites in myocardial tissue is dose-time dependent and related to cardiac hemodynamics in diabetic rats. Nutr Metab Cardiovasc Dis. 24(4):408–415.
   PubMed Web of Science ®Google Scholar
• Brioche T, Lemoine-Morel S. 2016. Oxidative stress, sarcopenia, antioxidant strategies and exercise: molecular aspects. CPD. 22(18):2664–2678.
   Google Scholar
• Chen Y, Tseng S-H. 2007. Pro- and anti-angiogenesis effects of resveratrol. In Vivo. 21(2):365–370.
   PubMed Web of Science ®Google Scholar
• Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ. 1996. Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem. 271(2):736–741.
   PubMed Web of Science ®Google Scholar
• Conley KE, Jubrias SA, Esselman PC. 2000. Oxidative capacity and ageing in human muscle. J Physiol. 526(1):203–210.
   PubMed Web of Science ®Google Scholar
• Dalle S, Rossmeislova L, Koppo K. 2017. The role of inflammation in age-related sarcopenia. Front Physiol. 8:1045.
   PubMed Web of Science ®Google Scholar
• Denison HJ, Cooper C, Sayer AA, Robinson SM. 2015. Prevention and optimal management of sarcopenia: a review of combined exercise and nutrition interventions to improve muscle outcomes in older people. Clin Interv Aging. 10:859–869.
   PubMed Web of Science ®Google Scholar
• Diaz M, Degens H, Vanhees L, Austin C, Azzawi M. 2016. The effects of resveratrol on aging vessels. Exp Gerontol. 85:41–47.
   PubMed Web of Science ®Google Scholar
• Dolinsky VW, Dyck JRB. 2014. Experimental studies of the molecular pathways regulated by exercise and resveratrol in heart, skeletal muscle and the vasculature. Molecules. 19(9):14919–14947.
   PubMed Web of Science ®Google Scholar
• Dutta S, Sengupta P. 2016. Men and mice: relating their ages. Life Sci. 152:244–248.
   PubMed Web of Science ®Google Scholar
• Flurkey K, Currer JM, Harrison DE. 2007. Mouse models in aging research. In: Fox JG, Davisson MT, Quimby FW, Barthold SW, Newcomer CE, Smith AL, editors. The mouse in biomedical research. Vol. 3. Amsterdam, The Netherlands: Elsevier Inc. p. 637–672.
   Google Scholar
• Giacomello E, Crea E, Torelli L, Bergamo A, Reggiani C, Sava G, Toniolo L. 2020. Age dependent modification of the metabolic profile of the tibialis anterior muscle fibers in C57BL/6J mice. IJMS. 21(11):3923.
   Google Scholar
• Giacomello E, Toniolo L. 2021. The potential of calorie restriction and calorie restriction mimetics in delaying aging: focus on experimental models. Nutrients. 13(7):2346.
   PubMed Web of Science ®Google Scholar
• Ilan N, Madri JA. 2003. PECAM-1: old friend, new partners. Curr Opin Cell Biol. 15(5):515–524.
   PubMed Web of Science ®Google Scholar
• Jackson JR, Ryan MJ, Alway SE. 2011. Long-term supplementation with resveratrol alleviates oxidative stress but does not attenuate sarcopenia in aged mice. J Gerontol A Biol Sci Med Sci. 66(7):751–764.
   PubMed Web of Science ®Google Scholar
• Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227(5259):680–685.
   PubMed Web of Science ®Google Scholar
• Larsson L, Degens H, Li M, Salviati L, Lee YI, Thompson W, Kirkland JL, Sandri M. 2019. Sarcopenia: Aging-related loss of muscle mass and function. Physiol Rev. 99(1):427–511.
   PubMed Web of Science ®Google Scholar
• Li H, Xia N, Hasselwander S, Daiber A. 2019. Resveratrol and vascular function. Int J Mol Sci. 20(9):2155.
   Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem. 193(1):265–275.
   PubMed Web of Science ®Google Scholar
• Madreiter-Sokolowski CT, Sokolowski AA, Graier WF. 2017. Dosis facit sanitatem—Concentration-dependent effects of resveratrol on mitochondria. Nutrients. 9(10):1117.
   Web of Science ®Google Scholar
• Nakata R, Takahashi S, Inoue H. 2012. Recent advances in the study on resveratrol. Biol Pharm Bull. 35(3):273–279.
   PubMed Web of Science ®Google Scholar
• Neuhoff V, Arold N, Taube D, Ehrhardt W. 1988. Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G‐250 and R‐250. Electrophoresis. 9(6):255–262.
   PubMed Web of Science ®Google Scholar
• Oellerich MF, Potente M. 2012. FOXOs and sirtuins in vascular growth, maintenance, and aging. Circ Res. 110(9):1238–1251.
   PubMed Web of Science ®Google Scholar
• Park EJ, Pezzuto JM. 2015. The pharmacology of resveratrol in animals and humans. Biochimica et Biophysica Acta – Mol Basis Dis. 1852(6):1071–1113.
   PubMed Web of Science ®Google Scholar
• Park S-J, Ahmad F, Philp A, Baar K, Williams T, Luo H, Ke H, Rehmann H, Taussig R, Brown AL, et al. 2012. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell. 148(3):421–433.
   PubMed Web of Science ®Google Scholar
• Penedo-Vázquez A, Duran X, Mateu J, López-Postigo A, Barreiro E. 2021. Curcumin and resveratrol improve muscle function and structure through attenuation of proteolytic markers in experimental cancer-induced cachexia. Molecules. 26(16):4904.
   PubMed Web of Science ®Google Scholar
• Pezzuto JM. 2011. The phenomenon of resveratrol: Redefining the virtues of promiscuity. Ann N Y Acad Sci. 1215(1):123–130.
   PubMed Web of Science ®Google Scholar
• Potente M, Ghaeni L, Baldessari D, Mostoslavsky R, Rossig L, Dequiedt F, Haendeler J, Mione M, Dejana E, Alt FW, et al. 2007. SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev. 21(20):2644–2658.
   PubMed Web of Science ®Google Scholar
• Privratsky JR, Newman DK, Newman PJ. 2010. PECAM-1: conflicts of interest in inflammation. Life Sci. 87(3-4):69–82.
   PubMed Web of Science ®Google Scholar
• Ramírez-Garza SL, Laveriano-Santos EP, Marhuenda-Muñoz M, Storniolo CE, Tresserra-Rimbau A, Vallverdú-Queralt A, Lamuela-Raventós RM. 2018. Health effects of resveratrol: results from human intervention trials. Nutrients. 10(12):1892.
   Web of Science ®Google Scholar
• Rezuş E, Burlui A, Cardoneanu A, Rezuş C, Codreanu C, Pârvu M, Rusu Zota G, Tamba BI. 2020. Inactivity and skeletal muscle metabolism: a vicious cycle in old age. IJMS. 21(2):592.
   Google Scholar
• Ringholm S, Olesen J, Pedersen JT, Brandt CT, Halling JF, Hellsten Y, Prats C, Pilegaard H. 2013. Effect of lifelong resveratrol supplementation and exercise training on skeletal muscle oxidative capacity in aging mice; impact of PGC-1α. Exp Gerontol. 48(11):1311–1318.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Bies E, Tung BT, Navas P, López-Lluch G. 2016. Resveratrol primes the effects of physical activity in old mice. Br J Nutr. 116(6):979–988.
   PubMed Web of Science ®Google Scholar
• Salehi B, Mishra AP, Nigam M, Sener B, Kilic M, Sharifi-Rad M, Fokou PVT, Martins N, Sharifi-Rad J. 2018. Resveratrol: A double-edged sword in health benefits. Biomedicines. 6(3):91.
   PubMed Web of Science ®Google Scholar
• Toniolo L, Formoso L, Torelli L, Crea E, Bergamo A, Sava G, Giacomello E. 2021. Long-term resveratrol treatment improves the capillarization in the skeletal muscles of ageing C57BL/6J mice. Int J Food Sci Nutr. 72(1):37–44.
   PubMed Web of Science ®Google Scholar
• Toniolo L, Fusco P, Formoso L, Mazzi A, Canato M, Reggiani C, Giacomello E. 2018. Resveratrol treatment reduces the appearance of tubular aggregates and improves the resistance to fatigue in aging mice skeletal muscles. Exp Gerontol. 111:170–179.
   PubMed Web of Science ®Google Scholar
• Toniolo L, Giacomello E. 2020. Resveratrol, aging, and fatigue. In: Preedy V, Patel V, editors. Aging. 2nd ed. San Diego, CA: Elsevier; p. 309–317. https://doi.org/https://doi.org/10.1016/b978-0-12-818698-5.00032-8
   Google Scholar
• Volpi N, Pecorelli A, Lorenzoni P, Di Lazzaro F, Belmonte G, Aglianò M, Cantarini L, Giannini F, Grasso G, Valacchi G. 2013. Antiangiogenic VEGF isoform in inflammatory myopathies. Mediators Inflamm. 2013:219313.
   PubMed Web of Science ®Google Scholar
• Wagner PD. 2011. The critical role of VEGF in skeletal muscle angiogenesis and blood flow. Biochem Soc Trans. 39(6):1556–1559.
   PubMedGoogle Scholar
• Wahl D, Bernier M, Simpson SJ, De Cabo R, Le Couteur DG. 2018. Future directions of resveratrol research. Nutr Healthy Aging. 4(4):287–290.
   PubMedGoogle Scholar
• Wang J, Leung KS, Chow SKH, Cheung WH. 2017. Inflammation and age-associated skeletal muscle deterioration (sarcopaenia). J Orthop Translat. 10:94–101.
   PubMed Web of Science ®Google Scholar
• Woodfin A, Voisin M-B, Nourshargh S. 2007. PECAM-1: a multi-functional molecule in inflammation and vascular biology. Arterioscler Thromb Vasc Biol. 27(12):2514–2523.
   PubMed Web of Science ®Google Scholar
• Xia N, Förstermann U, Li H. 2014. Resveratrol and endothelial Nitric oxide. Molecules. 19(10):16102–16121.
   PubMed Web of Science ®Google Scholar